Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

664 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Basket clinical trial design for targeted therapies for cancer: a French National Authority for Health statement for health technology assessment.
Lengliné E, Peron J, Vanier A, Gueyffier F, Kouzan S, Dufour P, Guillot B, Blondon H, Clanet M, Cochat P, Degos F, Chevret S, Grande M, Putzolu J; Transparency Committee of the French National Authority for Health. Lengliné E, et al. Among authors: chevret s. Lancet Oncol. 2021 Oct;22(10):e430-e434. doi: 10.1016/S1470-2045(21)00337-5. Lancet Oncol. 2021. PMID: 34592192 Review.
STAT3 Mediates Nilotinib Response in KIT-Altered Melanoma: A Phase II Multicenter Trial of the French Skin Cancer Network.
Delyon J, Chevret S, Jouary T, Dalac S, Dalle S, Guillot B, Arnault JP, Avril MF, Bedane C, Bens G, Pham-Ledard A, Mansard S, Grange F, Machet L, Meyer N, Legoupil D, Saiag P, Idir Z, Renault V, Deleuze JF, Hindie E, Battistella M, Dumaz N, Mourah S, Lebbe C; GCC (French Group of Skin Cancer). Delyon J, et al. Among authors: chevret s. J Invest Dermatol. 2018 Jan;138(1):58-67. doi: 10.1016/j.jid.2017.07.839. Epub 2017 Aug 24. J Invest Dermatol. 2018. PMID: 28843487 Free article. Clinical Trial.
Clinical phenotypes of critically ill COVID-19 patients.
Azoulay E, Zafrani L, Mirouse A, Lengliné E, Darmon M, Chevret S. Azoulay E, et al. Among authors: chevret s. Intensive Care Med. 2020 Aug;46(8):1651-1652. doi: 10.1007/s00134-020-06120-4. Epub 2020 May 28. Intensive Care Med. 2020. PMID: 32468086 Free PMC article. No abstract available.
Complement C5 inhibition in patients with COVID-19 - a promising target?
Peffault de Latour R, Bergeron A, Lengline E, Dupont T, Marchal A, Galicier L, de Castro N, Bondeelle L, Darmon M, Dupin C, Dumas G, Leguen P, Madelaine I, Chevret S, Molina JM, Azoulay E, Fremeaux-Bacchi V, Core Group. Peffault de Latour R, et al. Among authors: chevret s. Haematologica. 2020 Dec 1;105(12):2847-2850. doi: 10.3324/haematol.2020.260117. Haematologica. 2020. PMID: 33256385 Free PMC article. No abstract available.
Safety and efficacy of nivolumab, an anti-PD1 immunotherapy, in patients with advanced basal cell carcinoma, after failure or intolerance to sonic Hedgehog inhibitors: UNICANCER AcSé NIVOLUMAB trial.
Véron M, Chevret S, Grob JJ, Beylot-Barry M, Saiag P, Fléchon A, You B, Maubec E, Jouary T, Toulemonde E, Jamme P, Gambotti L, Lamrani-Ghaouti A, Dupuy A, Lebbe C, Seguin NB, Houede N, Leccia MT, Le Du F, de Pontville M, Gaudy-Marquestre C, Guillot B, Simon C, Marabelle A, Mortier L. Véron M, et al. Among authors: chevret s. Eur J Cancer. 2022 Dec;177:103-111. doi: 10.1016/j.ejca.2022.09.013. Epub 2022 Oct 11. Eur J Cancer. 2022. PMID: 36335780 Clinical Trial.
Incidence of liver abnormalities in Fanconi anemia patients.
Masserot-Lureau C, Adoui N, Degos F, de Bazelaire C, Soulier J, Chevret S, Socié G, Leblanc T. Masserot-Lureau C, et al. Among authors: chevret s. Am J Hematol. 2012 May;87(5):547-9. doi: 10.1002/ajh.23153. Epub 2012 Apr 10. Am J Hematol. 2012. PMID: 22488129 Free article.
664 results